InvestorsHub Logo

Jabramowitz

01/27/20 9:49 AM

#147 RE: Jabramowitz #146

from Alexion website:

Immune Pharma - anti-eotaxin-1 antibody
Phase: Preclinical


In November 2019, Alexion acquired an anti-eotaxin-1 antibody from Immune Pharma for potential development in inflammatory diseases.